{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T13:14:28Z","timestamp":1784553268819,"version":"3.55.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T00:00:00Z","timestamp":1733184000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T00:00:00Z","timestamp":1733184000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Department of Biotechnology, Government of West Bengal,India","award":["RD-37-2016"],"award-info":[{"award-number":["RD-37-2016"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"DOI":"10.1186\/s12876-024-03485-4","type":"journal-article","created":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T00:36:07Z","timestamp":1733186167000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Epidermal Growth Factor Receptor (EGFR) and SMAD4 negatively correlated in the progression of gallbladder cancer in Eastern Indian patients"],"prefix":"10.1186","volume":"24","author":[{"given":"Sounetra","family":"Choudhury","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandip","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prosenjeet","family":"Chakraborty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sayari","family":"Pal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koustuv","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subhankar","family":"Saha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jitesh","family":"Midha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinu","family":"Sankar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhisek","family":"Mohata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bitan Kumar","family":"Chattopadhyay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shibajyoti","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soumen","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biswarup","family":"Basu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nilabja","family":"Sikdar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,3]]},"reference":[{"key":"3485_CR1","doi-asserted-by":"publisher","first-page":"12211","DOI":"10.3748\/wjg.v21.i43.12211","volume":"21","author":"TO Goetze","year":"2015","unstructured":"Goetze TO. Gallbladder carcinoma: Prognostic factors and therapeutic options. World J Gastroenterol. 2015;21:12211\u20137.","journal-title":"World J Gastroenterol"},{"key":"3485_CR2","first-page":"77","volume":"75","author":"AB Lowenfels","year":"1985","unstructured":"Lowenfels AB, Lindstr\u00f6m CG, Conway MJ, et al. Gallstones and risk of gallbladder cancer. J Natl Cancer Inst. 1985;75:77\u201380.","journal-title":"J Natl Cancer Inst"},{"key":"3485_CR3","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1634\/theoncologist.2009-0302","volume":"15","author":"AX Zhu","year":"2010","unstructured":"Zhu AX, Hong TS, Hezel AF, et al. Current management of gallbladder carcinoma. Oncologist. 2010;15:168\u201381.","journal-title":"Oncologist"},{"issue":"1","key":"3485_CR4","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1186\/s12885-018-4575-3","volume":"18","author":"JM Nemunaitis","year":"2018","unstructured":"Nemunaitis JM, Brown-Glabeman U, Soares H, et al. Gallbladder cancer: Review of a rare orphan gastrointestinal cancer with a focus on populations of New Mexico. BMC Cancer. 2018;18(1):665.","journal-title":"BMC Cancer"},{"key":"3485_CR5","doi-asserted-by":"crossref","unstructured":"Domenico EG Di, Cavallo I, Pontone M, et al. Biofilm Producing Salmonella Typhi: Chronic Colonization and Development of Gallbladder Cancer. Int J Mol Sci 2017;18","DOI":"10.3390\/ijms18091887"},{"key":"3485_CR6","doi-asserted-by":"crossref","unstructured":"Cen L, Pan J, Zhou B, et al. Helicobacter Pylori infection of the gallbladder and the risk of chronic cholecystitis and cholelithiasis: A systematic review and meta-analysis. Helicobacter 2018;23","DOI":"10.1111\/hel.12457"},{"key":"3485_CR7","doi-asserted-by":"publisher","first-page":"111674","DOI":"10.1016\/j.mrfmmm.2019.111674","volume":"816\u2013818","author":"SK Mishra","year":"2019","unstructured":"Mishra SK, Kumari N, Krishnani N. Molecular pathogenesis of gallbladder cancer: An update. Mutat Res. 2019;816\u2013818:111674.","journal-title":"Mutat Res"},{"key":"3485_CR8","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.3748\/wjg.v22.i4.1335","volume":"22","author":"EI Marks","year":"2016","unstructured":"Marks EI, Yee NS. Molecular genetics and targeted therapeutics in biliary tract carcinoma. World J Gastroenterol. 2016;22:1335\u201347.","journal-title":"World J Gastroenterol"},{"key":"3485_CR9","doi-asserted-by":"publisher","first-page":"3978","DOI":"10.3748\/wjg.v23.i22.3978","volume":"23","author":"A Sharma","year":"2017","unstructured":"Sharma A, Sharma KL, Gupta A, et al. Gallbladder cancer epidemiology, pathogenesis and molecular genetics: Recent update. World J Gastroenterol. 2017;23:3978\u201398.","journal-title":"World J Gastroenterol"},{"key":"3485_CR10","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1007\/BF02913333","volume":"22","author":"MSK Naidu","year":"2007","unstructured":"Naidu MSK, Suryakar AN, Swami SC, et al. Oxidative stress and antioxidant status in cervical cancer patients. Indian J Clin Biochem. 2007;22:140\u20134.","journal-title":"Indian J Clin Biochem"},{"key":"3485_CR11","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1111\/j.1365-2559.2008.03192.x","volume":"55","author":"RD Goldin","year":"2009","unstructured":"Goldin RD, Roa JC. Gallbladder cancer: a morphological and molecular update. Histopathology. 2009;55:218\u201329.","journal-title":"Histopathology"},{"key":"3485_CR12","doi-asserted-by":"publisher","first-page":"3534","DOI":"10.3390\/ijms21103534","volume":"21","author":"J Dardare","year":"2020","unstructured":"Dardare J, Witz A, Merlin J-L, et al. SMAD4 and the TGF\u03b2 Pathway in Patients with Pancreatic Ductal Adenocarcinoma. Int J Mol Sci. 2020;21:3534.","journal-title":"Int J Mol Sci"},{"key":"3485_CR13","doi-asserted-by":"publisher","first-page":"9527","DOI":"10.2147\/CMAR.S268226","volume":"12","author":"SA Alqahtani","year":"2020","unstructured":"Alqahtani SA, Alghamdi IG. Epidemiology of gallbladder cancer in Saudi Arabia. Cancer Manag Res. 2020;12:9527\u201337.","journal-title":"Cancer Manag Res"},{"key":"3485_CR14","doi-asserted-by":"publisher","first-page":"35","DOI":"10.21037\/cco.2019.07.03","volume":"8","author":"MR Acharya","year":"2019","unstructured":"Acharya MR, Patkar S, Parray A, et al. Management of gallbladder cancer in India. Chin Clin Oncol. 2019;8:35.","journal-title":"Chin Clin Oncol"},{"key":"3485_CR15","doi-asserted-by":"publisher","first-page":"3","DOI":"10.31557\/apjec.2022.5.1.3-10","volume":"5","author":"S Singh","year":"2022","unstructured":"Singh S, Bhatnagar S, Lohia N, et al. Epidemiological and Geographical Profile of Gall Bladder Cancer Patients from a Hospital-based Registry of Northern Gangetic Plains. Asian Pac J Environ Cancer. 2022;5:3\u201310.","journal-title":"Asian Pac J Environ Cancer"},{"key":"3485_CR16","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1002\/ijc.10446","volume":"100","author":"U Sen","year":"2002","unstructured":"Sen U, Sankaranarayanan R, Mandal S, et al. Cancer patterns in eastern India: the first report of the Kolkata cancer registry. Int J Cancer. 2002;100:86\u201391.","journal-title":"Int J Cancer"},{"key":"3485_CR17","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.suronc.2010.09.003","volume":"21","author":"SK Maurya","year":"2012","unstructured":"Maurya SK, Tewari M, Mishra RR, et al. Genetic aberrations in gallbladder cancer. Surg Oncol. 2012;21:37\u201343.","journal-title":"Surg Oncol"},{"key":"3485_CR18","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1038\/sj.bjc.6690339","volume":"80","author":"M Matsushita","year":"1999","unstructured":"Matsushita M, Matsuzaki K, Date M, et al. Down-regulation of TGF-beta receptors in human colorectal cancer: implications for cancer development. Br J Cancer. 1999;80:194\u2013205.","journal-title":"Br J Cancer"},{"key":"3485_CR19","doi-asserted-by":"crossref","unstructured":"P\u00e9rez-Moreno P, Riquelme I, Garc\u00eda P, et al. Environmental and Lifestyle Risk Factors in the Carcinogenesis of Gallbladder Cancer. J Pers Med 2022;12","DOI":"10.3390\/jpm12020234"},{"key":"3485_CR20","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1038\/s41575-022-00726-3","volume":"20","author":"J Huang","year":"2023","unstructured":"Huang J, Lucero-Prisno DE, Zhang L, et al. Updated epidemiology of gastrointestinal cancers in East Asia. Nat Rev Gastroenterol Hepatol. 2023;20:271\u201387.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"3485_CR21","doi-asserted-by":"crossref","unstructured":"Verma P, Gupta P, Gupta N, et al. HER2\/ERBB2 overexpression in advanced gallbladder carcinoma: comprehensive evaluation by immunocytochemistry and fluorescence in situ hybridisation on fine-needle aspiration cytology samples. J Clin Pathol 2023;","DOI":"10.1136\/jcp-2023-208940"},{"key":"3485_CR22","first-page":"42","volume":"7","author":"I Roa","year":"2014","unstructured":"Roa I, de Toro G, Schalper K, et al. Overexpression of the HER2\/neu Gene: A New Therapeutic Possibility for Patients With Advanced Gallbladder Cancer. Gastrointest Cancer Res. 2014;7:42\u20138.","journal-title":"Gastrointest Cancer Res"},{"key":"3485_CR23","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1136\/gutjnl-2018-316039","volume":"68","author":"M Li","year":"2019","unstructured":"Li M, Liu F, Zhang F, et al. Genomic ERBB2\/ERBB3 mutations promote PD-L1-mediated immune escape in gallbladder cancer: a whole-exome sequencing analysis. Gut. 2019;68:1024\u201333.","journal-title":"Gut"},{"key":"3485_CR24","doi-asserted-by":"publisher","first-page":"69927","DOI":"10.18632\/oncotarget.12068","volume":"7","author":"S Moz","year":"2016","unstructured":"Moz S, Basso D, Bozzato D, et al. SMAD4 loss enables EGF, TGF\u03b21 and S100A8\/A9 induced activation of critical pathways to invasion in human pancreatic adenocarcinoma cells. Oncotarget. 2016;7:69927\u201344.","journal-title":"Oncotarget"},{"key":"3485_CR25","doi-asserted-by":"publisher","first-page":"2076","DOI":"10.1002\/ijc.25412","volume":"127","author":"S Zhao","year":"2010","unstructured":"Zhao S, Wang Y, Cao L, et al. Expression of oncogenic K-ras and loss of Smad4 cooperate to induce the expression of EGFR and to promote invasion of immortalized human pancreas ductal cells. Int J Cancer. 2010;127:2076\u201387.","journal-title":"Int J Cancer"},{"key":"3485_CR26","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1186\/1471-2407-14-181","volume":"14","author":"Y-W Chen","year":"2014","unstructured":"Chen Y-W, Hsiao P-J, Weng C-C, et al. SMAD4 Loss triggers the phenotypic changes of pancreatic ductal adenocarcinoma cells. BMC Cancer. 2014;14:181.","journal-title":"BMC Cancer"},{"key":"3485_CR27","doi-asserted-by":"crossref","unstructured":"Feng Z, Chen J, Wei H, et al. Feng et al. Exp Mol Pathol 2011;91:569\u201377.","DOI":"10.1016\/j.yexmp.2011.06.004"},{"key":"3485_CR28","doi-asserted-by":"publisher","first-page":"10","DOI":"10.4103\/1477-3163.139450","volume":"13","author":"DC Doval","year":"2014","unstructured":"Doval DC, Azam S, Sinha R, et al. Expression of epidermal growth factor receptor, p53, Bcl2, vascular endothelial growth factor, cyclooxygenase-2, cyclin D1, human epidermal receptor-2 and Ki-67: Association with clinicopathological profiles and outcomes in gallbladder carcinoma. J Carcinog. 2014;13:10.","journal-title":"J Carcinog"},{"key":"3485_CR29","doi-asserted-by":"crossref","unstructured":"Roa JC, Vo Q, Araya JC, et al. [Inactivation of CDKN2A gene (p16) in gallbladder carcinoma]. Rev Med Chil. 2004;132:1369\u201376.","DOI":"10.4067\/S0034-98872004001100005"},{"key":"3485_CR30","doi-asserted-by":"crossref","unstructured":"Ahmed S, Bradshaw A-D, Gera S, et al. The TGF-\u03b2\/Smad4 Signaling Pathway in Pancreatic Carcinogenesis and Its Clinical Significance. J Clin Med 2017;6","DOI":"10.3390\/jcm6010005"},{"key":"3485_CR31","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.cell.2008.07.001","volume":"134","author":"J Massagu\u00e9","year":"2008","unstructured":"Massagu\u00e9 J. TGF\u03b2 in Cancer. Cell. 2008;134:215\u201330.","journal-title":"Cell"},{"key":"3485_CR32","doi-asserted-by":"publisher","first-page":"33","DOI":"10.4137\/JCM.S40549","volume":"7","author":"M Yokoyama","year":"2016","unstructured":"Yokoyama M, Ohnishi H, Ohtsuka K, et al. KRAS Mutation as a Potential Prognostic Biomarker of Biliary Tract Cancers. Jpn Clin Med. 2016;7:33\u20139.","journal-title":"Jpn Clin Med"},{"key":"3485_CR33","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1038\/ng.3030","volume":"46","author":"M Li","year":"2014","unstructured":"Li M, Zhang Z, Li X, et al. Whole-exome and targeted gene sequencing of gallbladder carcinoma identifies recurrent mutations in the ErbB pathway. Nat Genet. 2014;46:872\u20136.","journal-title":"Nat Genet"},{"key":"3485_CR34","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1002\/ijc.31916","volume":"144","author":"P Iyer","year":"2019","unstructured":"Iyer P, Shrikhande SV, Ranjan M, et al. ERBB2 and KRAS alterations mediate response to EGFR inhibitors in early stage gallbladder cancer. Int J Cancer. 2019;144:2008\u201319.","journal-title":"Int J Cancer"},{"key":"3485_CR35","doi-asserted-by":"publisher","first-page":"9","DOI":"10.4103\/0377-4929.130849","volume":"57","author":"N Kumari","year":"2014","unstructured":"Kumari N, Corless CL, Warrick A, et al. Mutation profiling in gallbladder cancer in Indian population. Indian J Pathol Microbiol. 2014;57:9\u201312.","journal-title":"Indian J Pathol Microbiol"},{"key":"3485_CR36","doi-asserted-by":"publisher","first-page":"57","DOI":"10.31557\/apjcb.2021.6.1.57-65","volume":"6","author":"I Abeer","year":"2021","unstructured":"Abeer I, Khan S, Hasan Mohd J, et al. EGFR and HER2neu Expression in Gall Bladder Carcinoma and Its Association with Clinicopathological Parameters\u00a0- An Institutional Experience from North India. Asian Pac J Cancer Biol. 2021;6:57\u201365.","journal-title":"Asian Pac J Cancer Biol."},{"key":"3485_CR37","doi-asserted-by":"crossref","unstructured":"Sikdar N. The Geographical, Ethnic Variations and Risk factors of Gallbladder Carcinoma: A Worldwide View. J Investigative Genom 2016;3","DOI":"10.15406\/jig.2016.03.00051"},{"key":"3485_CR38","first-page":"209","volume":"16","author":"VK Kapoor","year":"2003","unstructured":"Kapoor VK, McMichael AJ. Gallbladder cancer: an \u201cIndian\u201d disease. Natl Med J India. 2003;16:209\u201313.","journal-title":"Natl Med J India"},{"key":"3485_CR39","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1289\/ehp.5966","volume":"111","author":"D Chakraborti","year":"2003","unstructured":"Chakraborti D, Mukherjee SC, Pati S, et al. Arsenic groundwater contamination in Middle Ganga Plain, Bihar, India: a future danger? Environ Health Perspect. 2003;111:1194\u2013201.","journal-title":"Environ Health Perspect"},{"key":"3485_CR40","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1158\/1055-9965.EPI-22-0926","volume":"32","author":"K Shridhar","year":"2023","unstructured":"Shridhar K, Krishnatreya M, Sarkar S, et al. Chronic Exposure to Drinking Water Arsenic and Gallbladder Cancer Risk: Preliminary Evidence from Endemic Regions of India. Cancer Epidemiol Biomarkers Prev. 2023;32:406\u201314.","journal-title":"Cancer Epidemiol Biomarkers Prev"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-024-03485-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-024-03485-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-024-03485-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T13:03:44Z","timestamp":1733231024000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/s12876-024-03485-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,3]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3485"],"URL":"https:\/\/doi.org\/10.1186\/s12876-024-03485-4","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,3]]},"assertion":[{"value":"8 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The studies involving human participants were reviewed and approved by the Institutional Research Ethics Review Board of every hospitals and institutions involved and the IRB certificate is attached. The two state hospitals included are Medical College & Hospital, Kolkata, SSKM & I.P.G.M.E.&R Hospital, Kolkata. The study was approved by the Institutional Ethics Committee of Indian Statistical Institute (ISI). The patients\/participants provided their written informed consent to participate in this study. All our methods followed the guidelines of the Helsinki declaration.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"446"}}